Pegylated Interferon for Treatment of Chronic Hepatitis C in Hemodialysis Patients in Croatia | Zendy

Nikolina BašićJukić | Zendy; Marijana Gulin | Zendy; Jasna Slaviček | Zendy; Valentina Čorić-Martinović | Zendy; Bosiljka Iskra | Zendy; Sanjin Rački | Zendy; Milenka Šain | Zendy; Rajko Ostojić | Zendy; Irena Hrstić | Zendy; Dragan Ljutić | Zendy; Boris Vucelić | Zendy; Petar Kes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pegylated Interferon for Treatment of Chronic Hepatitis C in Hemodialysis Patients in Croatia

Author(s) -

Nikolina BašićJukić,

Marijana Gulin,

Jasna Slaviček,

Valentina Čorić-Martinović,

Bosiljka Iskra,

Sanjin Rački,

Milenka Šain,

Rajko Ostojić,

Irena Hrstić,

Dragan Ljutić,

Boris Vucelić,

Petar Kes

Publication year - 2011

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000322922

Subject(s) - medicine , hemodialysis , dialysis , gastroenterology , hepatitis c virus , myalgia , hepatitis c , population , anemia , immunology , virus , environmental health

Hepatitis C virus (HCV) infection is a frequent complication among long-term dialysis patients. The aim of the present study was to evaluate the efficacy and side effects of pegylated interferon-α(2a) (PEG-IFN-α(2a)) treatment in hemodialysis patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research